Cite

HARVARD Citation

    Santini-Oliveira, M. et al. (2016). Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults. Vaccine. 34 (4), pp. 586-594. [Online]. 
  
Back to record